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Critical illness, resulting either from infection or from 
other pro-inﬂ  ammatory insults, is associated with severe 
immune dysfunction. However, little is known about how 
diﬀ   erent the dynamics of certain immune (especially 
suppressor) cell populations are depending on the type of 
primary insult. Hein and colleagues [1] investigated the 
role of naturally occurring T regulatory (Treg) cells in 43 
patients admitted to the ICU with shock due to sepsis 
and non-sepsis related etiologies. Th  e discriminating 
feature of the study is that it included most causes of 
shock, rather than limiting the scope to sepsis. In more 
detail, the authors compared the absolute numbers, 
percentages and kinetics of CD4+CD25+CD127- Treg cells 
in 26 critically ill patients with septic shock and 17 
patients with cardiogenic, hemorrhagic or toxic shock.
Naturally occurring CD4+CD25+ Treg cells comprise 5 
to 10% of CD4+ T cells and play a pivotal role in main-
taining immunologic homeostasis by inhibiting auto-
immunity and controlling inﬂ   ammation. Treg cells 
express the transcriptional regulator forkhead box p3 
(Foxp3), which belongs to the forkhead DNA-binding 
transcription factor family, and is essential for both the 
development and suppressive function of Treg cells [2]. 
Although their exact contribution in sepsis and shock has 
not been completely elucidated yet, evidence from a 
number of studies suggests that Treg cells act as 
signiﬁ  cant modulators of the innate and adaptive immune 
response after severe injury [3,4].
After trauma, Treg cell activity increased and was asso-
ciated with a decreased Th  1  pro-inﬂ  ammatory response, 
potentially contributing to injury-induced immuno-
paralysis, both in mice and in humans [5,6]. Moreover, in 
sepsis, not only the percentage of Treg cells was higher 
than in healthy volunteers [1,7], but their suppressive 
activity was enhanced as well, a phenomenon that 
correlated with increased expression of Foxp3 [8,9]. One 
explanation for the persistence of Treg cells after injury, 
despite CD4+CD25- and generalized lymphopenia [10], 
may be explained by their greater resistance to apoptosis 
[11]. Th  erefore, it is not surprising that Hein and 
colleagues [1] reported that the kinetics of Treg cells did 
not diﬀ  er signiﬁ  cantly between patients with septic and 
non-sepsis-related shock. Interestingly, survivors from 
the group of patients with septic shock had higher Treg 
cell counts and percentages than non-survivors, which 
remained consistent at all time points. Moreover, higher 
percentages of Treg cells were associated with lower 
blood arterial lactate and severity of illness score [1]. Th  is 
could suggest a protective role of Treg cells in sepsis, 
although the study’s small sample size precludes such a 
conclusion. It is also worth mentioning that this 
observation is contrary to the results published by 
Monneret and colleagues [7], where higher percentages 
of CD4+CD25+ cells were associated with worse prognosis 
in septic shock.
It is always very well received when information 
extracted from clinical studies is challenged in an 
experimental model. In the study by Hein and colleagues 
[1], Treg cell percentage increased early after poly-
microbial sepsis, but depletion of CD25+ cells did not 
aﬀ  ect survival in their model. Data on sepsis outcome 
from previously published studies that used similar 
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During the past decade, there have been an increasing 
number of studies investigating the precise role of 
T regulatory cells in human disease. First recognized 
for their ability to prevent autoimmunity, T regulatory 
cells control eff  ector CD4+ and CD8+ T lymphocytes and 
innate immune cells by several diff  erent suppressive 
mechanisms, like cell to cell contact, secretion of 
inhibitory cytokines and cytolysis. This suppressive 
function of T regulatory cells could contribute in a 
similar way to the profound immune dysfunction seen 
in critical illness whether the latter is due to sepsis or 
severe injury.
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[8,9,12]. On the other hand, adoptive transfer of in vitro 
stimulated Treg cells protected mice from lethality in a 
dose-dependent manner in a polymicrobial sepsis model 
[13], and decreased Toll-like receptor (TLR)-2- and TLR-4-
mediated pro-inﬂ   ammatory responses in an experi-
mental burn model [14]. At this point, however, a few 
important points need to be clariﬁ  ed: ﬁ  rst, anti-CD25 
antibody treatment may not have completely eliminated 
CD25-/Foxp3+ or CD25low/Foxp3+ Treg cells [15]; second, 
anti-CD25 treatment may also eliminate other activated 
cells that express CD25 [16]; and last, it may be useful to 
investigate whether antibody depletion, if performed 
later in the course of shock after the pro-inﬂ  ammatory 
insult has ampliﬁ  ed the regulatory activity of CD4+CD25+ 
Treg cells, could then potentially lead to a diﬀ  erent 
outcome [3].
Even if no great variability exists between the kinetics 
and activity of Treg cells in diﬀ  erent shock states, the 
sequence and timing of events that lead to the 
ampliﬁ  cation of their suppressive function certainly need 
to be studied further.
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